EA201991046A1 - Рестимуляция криоконсервированных опухоль-инфильтрирующих лимфоцитов - Google Patents
Рестимуляция криоконсервированных опухоль-инфильтрирующих лимфоцитовInfo
- Publication number
- EA201991046A1 EA201991046A1 EA201991046A EA201991046A EA201991046A1 EA 201991046 A1 EA201991046 A1 EA 201991046A1 EA 201991046 A EA201991046 A EA 201991046A EA 201991046 A EA201991046 A EA 201991046A EA 201991046 A1 EA201991046 A1 EA 201991046A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- restimulation
- infiltrating lymphocytes
- cryopreserved tumor
- til
- methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/04—Immunosuppressors, e.g. cyclosporin, tacrolimus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2302—Interleukin-2 (IL-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/11—Coculture with; Conditioned medium produced by blood or immune system cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Настоящее изобретение относится к способам рестимуляции популяций TIL, приводящей к улучшению фенотипа и к усилению метаболического дыхания TIL, а также к способам анализа на популяции TIL для определения возможности их более эффективной инфузии после рестимуляции.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662415452P | 2016-10-31 | 2016-10-31 | |
PCT/US2017/058610 WO2018081473A1 (en) | 2016-10-26 | 2017-10-26 | Restimulation of cryopreserved tumor infiltrating lymphocytes |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201991046A1 true EA201991046A1 (ru) | 2020-01-29 |
Family
ID=69374509
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201991046A EA201991046A1 (ru) | 2016-10-31 | 2017-10-26 | Рестимуляция криоконсервированных опухоль-инфильтрирующих лимфоцитов |
Country Status (1)
Country | Link |
---|---|
EA (1) | EA201991046A1 (ru) |
-
2017
- 2017-10-26 EA EA201991046A patent/EA201991046A1/ru unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2019004707A (es) | Reestimulacion de linfocitos infiltrantes de tumor crioconservados. | |
MX2019005199A (es) | Métodos para evaluar el riesgo usando and libre de células total y específico. | |
EA201891293A1 (ru) | Мультиспецифические антитела | |
BR112018010927A2 (pt) | anticorpos multiespecíficos | |
CL2016002455A1 (es) | Anticuerpos multiespecíficos. | |
EA201791029A1 (ru) | Антитела против интерлейкина-33 и их применение | |
EA201590993A1 (ru) | Гетеродимерные иммуноглобулины | |
EA201892489A1 (ru) | Число мишеней для мультиплексной оптимизированной амплификации с несоответствиями (moma) | |
EA201592213A1 (ru) | Антитела антирецептор трансферрина и способы их использования | |
EA201690617A1 (ru) | Комбинирование anti-lag-3-антител и анти-pd-1-антител для лечения опухолей | |
EA201792613A1 (ru) | Модуляторы cot и способы их применения | |
EA201891291A1 (ru) | Мультиспецифические антитела | |
EA201592269A1 (ru) | Способы и композиции для снижения иммуносупрессии опухолевыми клетками | |
EA202193044A2 (ru) | Способы лечения таупатии | |
EA201491574A1 (ru) | Применение car, основанных на icos, для усиления противоопухолевой активности и длительного сохранения car | |
MX2016014684A (es) | Nuevo formato biespecifico adecuado para uso en tamizado de alto rendimiento. | |
EA201591740A1 (ru) | Вирусы болезни ньюкасла и их применение | |
EA201591283A1 (ru) | Количественная оценка эффективности кэп матричной рнк | |
EA201590027A1 (ru) | Способы детекции заболеваний или состояний | |
EA201401077A1 (ru) | Биспецифические антитела к человеческому tweak и человеческому il17 и их применения | |
EA201491811A1 (ru) | АНТИ-LgR5 АНТИТЕЛА И ИММУНОКОНЪЮГАТЫ | |
NZ761537A (en) | Anti-human ox40l antibodies, uses & methods | |
CL2015002724A1 (es) | Métodos para tratar la enfermedad de crohn utilizando un anticuerpo anti-il23 | |
CU24405B1 (es) | Proteínas de variantes de secuencias de aminoácidos de cry1da1 activas para lepidópteros | |
EA201591926A1 (ru) | Способ многоцветной проточной цитометрии для идентификации популяции клеток, в частности мезенхимальных стволовых клеток |